Mohr–Tranebjærg syndrome
Mohr–Tranebjærg syndrome is a rare X-linked recessive syndrome also known as deafness–dystonia syndrome and caused by mutation in the TIMM8A gene. It is characterized by clinical manifestations commencing with early childhood onset hearing loss, followed by adolescent onset progressive or, visual impairment from early adulthood onwards and dementia from the 4th decade onwards. The severity of the symptoms may vary, but they progress usually to severe deafness and dystonia and sometimes are accompanied by cortical deterioration of vision and mental deterioration.
Signs and symptoms
Mohr-Tranebjærg is characterized by a variety of symptoms affecting hearing loss. In the span of a subject with Mohr-Tranebjærg, by the age of early childhood, around 18 months, the development of quickly progressive prelingual or postlingual sensorineural hearing loss. The presence of auditory symptoms is characterized by preserved oto-acoustic emissions, abnormal auditory brain stem response, poor speech, and worsening in auditory symptoms even with auditory devices. Also, neuropsychological manifestations, possibly consisting of personality changes, paranoia, and mild intellectual deficit could emerge. During adolescence, there is a possibility that a slowly progressive movement disorder, similar to gegenhalten, dystonia, or ataxia could develop. Patients with Mohr-Tranebjærg experience reduced visual acuity, photophobia, acquired color vision defect and central scotomas developing at around 20 years of age, and leading to more severe blindness by age 30 or 40.The first symptom of DDON syndrome is hearing loss caused by nerve damage in the inner ear, which begins in early childhood. The hearing impairment worsens over time, and most affected individuals have profound hearing loss by age 10.
Individuals with Mohr Tranebjærg syndrome have normal vision during childhood, but they may develop vision problems due to breakdown of the nerves that carry information from the eyes to the brain. Affected individuals can develop an increased sensitivity to light or other vision problems beginning in adolescence. Their sharpness of vision slowly worsens, often leading to legal blindness in mid-adulthood.
Genetics
This condition is caused by mutations in the TIMM8A gene. This gene is located on the long arm of X chromosome.The protein encoded by this gene localizes to the intermembrane space in mitochondria where it functions in the import of nuclear encoded proteins into the mitochondrial inner membrane. How this produces the clinical picture is not yet clear.
The pattern of inheritance is X-linked recessive. Where the female is a carrier, male offspring have a 50 percent chance of inheriting the disease and female offspring have a 50 percent chance of being a carrier. Where the male is affected, male offspring do not inherit the pathogenic mutation and females are obligate carriers.
TIMM8A is also referred to as DDP. Koehler determined the function of the DDP gene and concluded that the Mohr-Tranebjaerg syndrome is a novel type of mitochondrial disease that is most likely caused by a defective mitochondrial protein-import system.
Diagnosis
A combination of hearing impairment and recurrent infections due to XLA in a male patient should elicit sequencing of the TIMM8A gene. Neuroimaging is employed to verify the presence of cerebral atrophy. In cases of suspected CGS; testing for XLA is possible.Differential diagnosis
This is long and includes- Arts syndrome
- Autosomal recessive nonsyndromic sensorineural deafness type DFNB
- Friedreich ataxia
- MELAS syndrome
- Mitochondrial DNA depletion syndrome
- McLeod neuroacanthocytosis syndrome
- Pendred syndrome
- Usher syndrome type 1 and 2
- Wolfram syndrome
- X-linked spinocerebellar ataxia type 3 and 4